Related Experiment Video
Updated: May 30, 2026

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
Published on: February 24, 2026
ALS genetic modifiers that increase survival of SOD1 mice and are suitable for therapeutic development
Giulietta Riboldi1, Monica Nizzardo, Chiara Simone
1Department of Neurological Sciences, Dino Ferrari Centre, University of Milan, IRCCS Fondazione Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
Abstract:
Amyotrophic lateral sclerosis (ALS) is a frequently fatal motor neuron disease without any cure. To find molecular therapeutic targets, several studies crossed transgenic ALS murine models with animals transgenic for some ALS target genes. We aimed to revise the new discoveries and new works in this field. We selected the 10 most promising genes, according to their capability when down-regulated or up-regulated in ALS animal models, for increasing life span and mitigating disease progression: XBP-1, NogoA and NogoB, dynein, heavy and medium neurofilament, NOX1 and NOX2, MLC-mIGF-1, NSE-VEGF, and MMP-9. Interestingly, some crucial modifier genes have been described as being involved in common pathways, the most significant of which are inflammation and cytoskeletal activities. The endoplasmic reticulum also seems to play an important role in ALS pathogenesis, as it is involved in different selected gene pathways. In addition, these genes have evident links to each other, introducing the hypothesis of a single unknown, common pathway involving all of these identified genes and others to be discovered.
Insights
Researchers reviewed 10 key genes in animal models of Amyotrophic Lateral Sclerosis (ALS). Modifying these genes may extend lifespan and slow disease progression in this motor neuron disease.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Amyotrophic Lateral Sclerosis (ALS) is a fatal motor neuron disease with no current cure.
- Identifying molecular therapeutic targets is crucial for developing effective treatments for ALS.
- Transgenic animal models are instrumental in studying ALS pathogenesis and evaluating potential therapeutic genes.
Purpose of the Study:
- To review recent discoveries and research on potential molecular therapeutic targets for ALS.
- To identify and analyze the 10 most promising genes that, when modulated, could impact ALS progression and lifespan in animal models.
- To explore the interconnectedness of these genes and their involvement in common pathogenic pathways.
Main Methods:
- Systematic review of studies involving transgenic ALS murine models crossed with animals expressing specific ALS target genes.
- Selection of 10 key genes based on their demonstrated impact (up-regulation or down-regulation) on lifespan and disease mitigation in ALS animal models.
- Analysis of identified genes for involvement in common biological pathways, including inflammation, cytoskeletal activity, and endoplasmic reticulum function.
Main Results:
- Ten genes (XBP-1, NogoA/B, dynein, heavy/medium neurofilament, NOX1/2, MLC-mIGF-1, NSE-VEGF, MMP-9) were identified as promising targets.
- Common pathways implicated in ALS pathogenesis include inflammation and cytoskeletal dynamics.
- The endoplasmic reticulum plays a significant role in various selected gene pathways relevant to ALS.
Conclusions:
- Modulating the identified genes holds potential for increasing lifespan and mitigating disease progression in ALS.
- Inflammation, cytoskeletal activities, and endoplasmic reticulum function are critical interconnected pathways in ALS pathogenesis.
- The findings suggest a potential underlying common pathway that links these identified genes and possibly others yet to be discovered in ALS.
More Related Videos
Related Concept Videos
In-vitro Mutagenesis
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

